Workup for Type 4 Renal Tubular Acidosis
The workup for type 4 RTA requires confirming three key features: hyperkalemia, non-anion gap metabolic acidosis with hyperchloremia, and evidence of aldosterone deficiency or resistance through a low transtubular potassium gradient (TTKG) and urine pH <5.5.
Initial Laboratory Assessment
Start with basic metabolic panel and arterial blood gas to establish:
- Hyperkalemia (typically >5.5 mEq/L)
- Non-anion gap metabolic acidosis (anion gap <12 mEq/L) with hyperchloremia
- Serum bicarbonate typically 15-20 mEq/L 1, 2
The presence of hyperkalemia with normal anion gap metabolic acidosis immediately distinguishes type 4 from types 1 and 2 RTA, which present with hypokalemia 3.
Confirmatory Testing
Urine Studies
Obtain simultaneous urine and serum samples for:
- Urine pH: Should be <5.5 in type 4 RTA (the kidneys can still acidify urine, unlike type 1 RTA) 4, 2
- Urine sodium, potassium, and creatinine for TTKG calculation
- Urine anion gap: Typically positive in RTA
Transtubular Potassium Gradient (TTKG)
Calculate TTKG using: (Urine K × Serum Osm) / (Serum K × Urine Osm)
- TTKG <5 (often <3) confirms impaired potassium secretion consistent with aldosterone deficiency or resistance 4
- A TTKG <5 in the setting of hyperkalemia indicates the kidney cannot appropriately excrete potassium
Assess Renal Function
- Serum creatinine and eGFR: Type 4 RTA often occurs with only moderately impaired GFR (eGFR 25-60 mL/min/1.73 m²) 5
- Important caveat: Type 4 RTA should be suspected when hyperkalemia is disproportionate to the degree of renal impairment 5
Determine Underlying Etiology
Medication Review
Identify drugs that can cause type 4 RTA:
- Calcineurin inhibitors (tacrolimus, cyclosporine) 4
- RAAS antagonists (ACE inhibitors, ARBs, aldosterone antagonists) 5
- NSAIDs
- Heparin
- Trimethoprim, pentamidine
Aldosterone Assessment
Measure to differentiate aldosterone deficiency from resistance:
- Plasma renin activity
- Serum aldosterone level
- Aldosterone-to-renin ratio
Low renin and low aldosterone suggests hyporeninemic hypoaldosteronism (most common in diabetic nephropathy) 5, 6
High renin with low aldosterone suggests primary adrenal insufficiency
High aldosterone with hyperkalemia suggests aldosterone resistance (pseudohypoaldosteronism)
Screen for Common Causes
- Diabetes mellitus: Most common cause, especially with diabetic nephropathy 5
- Tubulointerstitial disease: Chronic pyelonephritis, obstructive uropathy
- Adrenal insufficiency: Consider if other features present (hypotension, hyponatremia)
Exclude Pseudohyperkalemia
Before extensive workup, rule out:
- Hemolysis in blood sample
- Thrombocytosis or leukocytosis (release K from cells)
- Prolonged tourniquet time during phlebotomy
- Plasma vs serum measurement differences 7
Common Pitfalls
Do not attribute hyperkalemia solely to acute kidney injury or RAAS inhibitors when creatinine is only moderately elevated—42% of significantly hyperkalemic patients have underlying type 4 RTA 5. The combination of preserved acidification (urine pH <5.5), low TTKG, and hyperkalemia with non-anion gap acidosis confirms the diagnosis even in the presence of AKI 4, 5.
Monitor for diurnal and seasonal variation in potassium measurements, as these can affect interpretation 7.